You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 2020190067
Dec 202056013
Jan 20212405
Feb 20211806
Mar 20215008
Apr 20213009
May 2021207
Jun 2021009
Jul 2021005
Aug 20210011
Sep 20210012
Oct 202120027
Nov 202152018
Dec 20213602
Jan 202246010
Feb 20224005
Mar 20221600
Apr 20223205
May 20222604
Jun 20223203
Jul 20221001
Aug 20221802
Sep 20221403
Oct 20221400
Nov 20221402
Dec 20221800
Jan 20233605
Feb 20232800
Mar 20231203
Apr 20232201
May 20231600
Jun 20231200
Jul 20231803
Aug 20231804
Sep 2023600
Oct 20232604
Nov 20231605
Dec 20234200
Jan 20241801
Feb 20241200
Mar 20243202
Apr 20241202
May 20243203
Jun 20241801
Jul 20241201
Aug 20242800
Sep 20242004
Oct 20242002
Nov 20241804
Total12320279